First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer.

Zarkar, Anjali; Henderson, Dan; Carver, Antony; Heyes, Geoff; Harrop, Victoria; Tutill, Sarah; Kilkenny, Julie; Marshall, Andrea; Elbeltagi, Nada; Howard, Helen

Zarkar, Anjali; Henderson, Dan; Carver, Antony; Heyes, Geoff; Harrop, Victoria; Tutill, Sarah; Kilkenny, Julie; Marshall, Andrea; Elbeltagi, Nada; Howard, Helen.

Afiliação

Zarkar A; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Henderson D; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Carver A; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Heyes G; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Harrop V; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Tutill S; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Kilkenny J; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Marshall A; Warwick Clinical Trials Unit Warwick UK.
Elbeltagi N; Warwick Clinical Trials Unit Warwick UK.
Howard H; University Hospitals Birmingham NHS Foundation Trust Birmingham UK.

BJUI Compass ; 4(4): 464-472, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37334027

Palavras-chave

SABR; SABR for primary RCC; SBRT; SBRT for primary RCC; primary kidney SABR; stereotactic ablative radiotherapy; stereotactic radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article